Clincosm LogoSign in Get a demo

Obesity

Showing NaN - NaN of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Cardiovascular Diseases Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • Cardiovascular Diseases
  • Phoenix, Arizona
  • +165 more
May 22, 2023

Obesity Trial in Worldwide (Cagrilintide, Semaglutide, Placebo)

Not yet recruiting
  • Obesity
  • Birmingham, Alabama
  • +253 more
Jan 24, 2023

Obesity Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

Recruiting
  • Obesity
  • Birmingham, Alabama
  • +225 more
Jan 24, 2023

Pro-opiomelanocortin (POMC) Deficiency Obesity (Heterozygous or Epigenetic), Leptin Receptor Deficiency Obesity, Smith-Magenis

Completed
  • Genetic Obesity
  • +2 more
  • Birmingham, Alabama
  • +57 more
Dec 22, 2022

Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +804 more
Dec 19, 2022

Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Obesity
  • Fairhope, Alabama
  • +97 more
Jun 15, 2022

Type 2 Diabetes, Obesity Trial in Cambridge (0.9% Sodium-chloride, Exenatide (50ng/min for 30 minutes loading followed by

Recruiting
  • Type 2 Diabetes
  • Obesity
  • 0.9% Sodium-chloride
  • +3 more
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust and The Univ
Jan 18, 2022

Diabetes, Type II, Obesity Trial in Cambridge (MEDI0382, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type II
  • Obesity
  • Cambridge, United Kingdom
    Research Site
Feb 11, 2021

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (semaglutide, liraglutide, )

Completed
Has Results
  • Metabolism and Nutrition Disorder
  • Obesity
  • Anaheim, California
  • +73 more
Apr 14, 2020

Obesity Trial in Worldwide (JNJ-64565111 Dose Level 1, JNJ-64565111 Dose Level 2, JNJ-64565111 Dose Level 3)

Completed
Has Results
  • Obesity
  • JNJ-64565111 Dose Level 1
  • +4 more
  • Phoenix, Arizona
  • +50 more
Jan 14, 2020

Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

Completed
Has Results
  • Cardiovascular Disease
  • +4 more
  • Lorcaserin hydrochloride
  • Placebo
  • Alexander City, Alabama
  • +498 more
Jun 27, 2019

High School Football and Adult Health

Completed
  • Health Impairment
  • +2 more
    • Cambridge, Massachusetts
    • +1 more
    Apr 16, 2019

    Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

    Completed
    Has Results
    • Metabolism and Nutrition Disorder
    • Obesity
    • Birmingham, Alabama
    • +225 more
    Dec 20, 2017

    Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

    Completed
    Has Results
    • Metabolism and Nutrition Disorder
    • Obesity
    • Vestavia Hills, Alabama
    • +160 more
    Dec 6, 2017

    Diabetes, Type 2, Obesity Trial in Cambridge (GW869682, GSK189075, GSK189075-Placebo)

    Completed
    • Diabetes Mellitus, Type 2
    • Obesity
    • Cambridge, Cambridgeshire, United Kingdom
      GSK Investigational Site
    Aug 4, 2017

    Obesity Trial in Cambridge (GSK1521498 or )

    Completed
    • Obesity
    • GSK1521498 or placebo
    • Cambridge, Cambridgeshire, United Kingdom
      GSK Investigational Site
    Jun 23, 2017

    Obesity Trial in Cambridge (sibutramine, sibutramine )

    Completed
    • Obesity
    • Cambridge, Cambridgeshire, United Kingdom
      GSK Investigational Site
    Jun 16, 2017

    Obesity Trial in Cambridge (Zolpidem or - Hypnotic drug given for sleep disorders, GSK1521498 or )

    Completed
    • Obesity
    • Zolpidem or placebo - Hypnotic drug given for sleep disorders
    • GSK1521498 or placebo
    • Cambridge, Cambridgeshire, United Kingdom
      GSK Investigational Site
    Jun 19, 2017

    Obesity Trial in Cambridge, Birmingham, London (GSK1521498, Placebo)

    Completed
    • Obesity
    • Cambridge, Cambridgeshire, United Kingdom
    • +2 more
    Nov 30, 2016

    Sedentary Lifestyle, Obesity Trial in Cambridge (Financial incentives for increasing physical exercise)

    Withdrawn
    • Sedentary Lifestyle
    • Obesity
    • Financial incentives for increasing physical exercise
    • Cambridge, Massachusetts
      Genzyme
    Jun 23, 2015

    Obesity Trial in Cambridge (High calorie lunch, Breakfast)

    Terminated
    • Obesity
    • High calorie lunch
    • Breakfast
    • Cambridge, United Kingdom
      GSK Investigational Site
    Aug 11, 2014

    Overweight, Obesity Trial in Philadelphia, Houston, Cambridge (online lifestyle counseling and a fortified diet beverage)

    Completed
    • Overweight
    • Obesity
    • online lifestyle counseling and a fortified diet beverage
    • Philadelphia, Pennsylvania
    • +2 more
    Dec 14, 2011

    European Study of Cardiovascular Risk

    Completed
    • Cardiovascular Risk Factors
    • +5 more
      • Alland, Austria
      • +777 more
      Oct 28, 2009